About
Contact & Profiles
A5027519877
Research Areas
- Muscle Physiology and Disorders
- Prosthetics and Rehabilitation Robotics
- Stroke Rehabilitation and Recovery
- Congenital heart defects research
- Receptor Mechanisms and Signaling
- Cell Adhesion Molecules Research
Oregon Health & Science University
2024
Boston Children's Hospital
2024
National Institutes of Health
2018-2020
Omigapil is a small molecule which inhibits the GAPDH-Siah1-mediated apoptosis pathway. Apoptosis pathomechanism underlying congenital muscular dystrophy subtypes LAMA2-related (LAMA2-RD) and COL6-related (COL6-RD). Studies of omigapil in (dy
10.1212/nxg.0000000000200148
article
EN
cc-by-nc-nd
Neurology Genetics
2024-05-29
10.1016/j.nmd.2018.06.082
article
EN
Neuromuscular Disorders
2018-09-05
10.1016/j.nmd.2020.08.245
article
EN
Neuromuscular Disorders
2020-09-28
Coming Soon ...